CTOs on the Move

Pacific Oak Capital Advisors

www.pacificoakcapitaladvisors.com

 
Pacific Oak Capital Advisors is an alternative investment company that focuses on sponsoring and providing quality investment opportunities to financial advisors, registered investment advisors and institutional investors. The company was formed in 2018 by Keith Hall and Peter McMillan, previously senior executives with one of the most successful alternative investment firms in the nation, where they completed transaction volume in excess of $15 billion of real estate equity and debt over the course of 13 years. McMillan serves as chairman of Pacific Oak Strategic Opportunity REIT, while Hall serves as chief executive officer of the real estate investment trust. In ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Tiedemann Advisors

Tiedemann Advisors is one of the largest independent investment and wealth advisors for high-net-worth individuals, families, trusts, foundations and endowments. Founded in 1999, Tiedemann has nine offices across the U.S. including its trust services office, Tiedemann Trust Company, a state-chartered trust company located in Wilmington, Delaware.

Berkshire Axis

Berkshire Axis is a Toronto, ON-based company in the Financial Services sector.

Shelter Capital Partners

Shelter Capital Partners is one of the leading companies in the Financial Services sector.

Lake Harriet Capital

Lake Harriet Capital, LLC is a Minneapolis, MN based family office founded in 2016 to manage the investment assets for the family of James A. Lawrence. The firm invests its own capital and that of other family offices and institutions with a primary focus on opportunistic and value-add public and private market strategies in commercial real estate, consumer products, and airline/aircraft related businesses.

Omega Fund

Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world`s most urgent medical needs. Ω is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies. We are guided by our conviction in people, products and breakthrough ideas, not by conventional categories. Our investments span a variety of instruments from early venture rounds, to late-stage investing, direct secondary transactions, as well as company founding and creation. Omega Funds has raised more than $1 billion since its inception in 2004 and is headquartered in Boston, Massachusetts, USA.